Navigating the Changing Geographic Atrophy Landscape: A Guide for Clinicians
Provider: Macular Disease Foundation Australia - Health Professional Education and Training
Course access: https://lms.optometry.org.au/course/view.php?id=765
Activity Outline
Recent advancements in clinical trials have shown potential new treatment options for people with geographic atrophy. Due to the pending arrival of these treatments in Australia, it is advised that clinicians provide appropriate counselling and/or non-urgent referral to ophthalmology for baseline testing of geographic atrophy in patients interested in new treatments. Macular Disease Foundation Australia has developed this Government funded guide covering an overview of geographic atrophy, including classification, risk factors, imaging, features associated with progression and an update on treatments.
Learning Objectives
- Describe the prevalence and classification of geographic atrophy
- Understand the modifiable and non-modifiable risk factors associated with risk of progression to late AMD
- Describe key imaging techniques to diagnose and manage geographic atrophy
- Understand the current treatments available for geographic atrophy and how to communicate their risks and benefits with patients
Max CPD hours awarded: 1.25
Session Information
| Name |
|---|
| Navigating the changing Geographic Atrophy Landscape: A Guide for clinicians |
| Clinical? |
| Yes |
| Interactive? |
| No |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 1.25 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 1.25 |